PRI's Focus on Health Care

View this email in your browser ([link removed])
[link removed]
Insurance Market Requiring Gov't Handouts Is Dysfunctional

Newsmax | Sally Pipes
October 27, 2022

Next week marks the beginning of open enrollment on the health insurance exchanges created by the Affordable Care Act. According to one recent analysis ([link removed]) of 72 exchange insurers, premiums are likely to increase by an average of 10%. In some cases, rate hikes could exceed 25%.

Read more. . . ([link removed])

Health Care Priorities for Next Congress

Right by the Bay | McKenzie Richards
October 31, 2022

Election day approaches quickly. But no matter who wins come November, Americans must urge Congress to prioritize health care policy.

Health care costs are consistently rising ([link removed]) which endangers lives because costs can constrain patients from receiving needed care ([link removed]) . Pandemic exigencies further highlighted shortcomings in our health care system. Before pandemic lessons are forgotten, the next Congress should prioritize implementing health care policies according to what was learned.

Read more. . . ([link removed])

Americans Don't Want Single-Payer Revolution

The Detroit News | Sally Pipes
October 27, 2022

America’s private health insurance system is beyond saving, we’re often told by advocates of Medicare for All. As they see it, the only path forward is to abolish private coverage and replace it with a single government-run program.

Read more . . . ([link removed])

Human insulin saga: Anomalous, successful 40-year history of the first genetically-modified medicine underscores how regulators can scuttle innovation

Genetic Literacy Project | Henry Miller
October 27, 2022

October 29th marks the 40th anniversary of one of biotechnology’s most significant milestones — the approval by the FDA of human insulin synthesized in genetically engineered bacteria to treat diabetes. The first “biopharmaceutical,” or drug made with molecular genetic engineering techniques, to be approved, it launched a revolutionary era in drug development.

Read more . . . ([link removed])

============================================================
** ([link removed])
** ([link removed])
** ([link removed])
** ([link removed])
** ([link removed])
** ([link removed])
Copyright © 2022 *Pacific Research Institute*, All rights reserved.
You are receiving this email because you opted in via our website.

Our mailing address is:
P.O. Box 60485 | Pasadena, CA 91116

Want to change how you receive these emails?
You can ** update your preferences ([link removed])
or ** unsubscribe from this list ([link removed])
.